BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 34491710)

  • 1. Drug Prescribing: Polypharmacy and Deprescribing.
    McQuade BM; Campbell A
    FP Essent; 2021 Sep; 508():33-40. PubMed ID: 34491710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
    Chou J; Tong M; Brandt NJ
    J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
    Triantafylidis LK; Hawley CE; Perry LP; Paik JM
    Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
    Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
    J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationalizing prescription via deprescribing in oncology practice.
    Raju B; Chaudhary RK; L A; Babu A; Sandeep A; Mateti UV
    J Oncol Pharm Pract; 2023 Dec; 29(8):2007-2013. PubMed ID: 37847585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy, the Elderly, and Deprescribing.
    Jetha S
    Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
    Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
    PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing: a new goal focused on the patient.
    Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME; Chica L
    Expert Opin Drug Saf; 2017 Feb; 16(2):111-112. PubMed ID: 27984921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy: Evaluating Risks and Deprescribing.
    Halli-Tierney AD; Scarbrough C; Carroll D
    Am Fam Physician; 2019 Jul; 100(1):32-38. PubMed ID: 31259501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprescribing medications in older people: a narrative review.
    Salahudeen MS
    Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LESS-PHARMA Study: Identifying and Deprescribing Potentially Inappropriate Medication in the Elderly Population with Excessive Polypharmacy in Primary Care.
    Reus X; Sastre ML; Leiva A; Sánchez B; García-Serra C; Ioakeim-Skoufa I; Vicens C
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy Reduction Strategies: Tips on Incorporating American Geriatrics Society Beers and Screening Tool of Older People's Prescriptions Criteria.
    Levy HB
    Clin Geriatr Med; 2017 May; 33(2):177-187. PubMed ID: 28364990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
    Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
    Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences.
    Bondurant-David K; Dang S; Levy S; Sperlea D; Vanier MC; Gerardi S; David PM
    Int J Pharm Pract; 2020 Dec; 28(6):635-642. PubMed ID: 33094884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.
    Rochon PA; Petrovic M; Cherubini A; Onder G; O'Mahony D; Sternberg SA; Stall NM; Gurwitz JH
    Lancet Healthy Longev; 2021 May; 2(5):e290-e300. PubMed ID: 36098136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
    Komagamine J; Sugawara K; Hagane K
    BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods to reduce prescribing errors in elderly patients with multimorbidity.
    Lavan AH; Gallagher PF; O'Mahony D
    Clin Interv Aging; 2016; 11():857-66. PubMed ID: 27382268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.
    Farrell B; Tsang C; Raman-Wilms L; Irving H; Conklin J; Pottie K
    PLoS One; 2015; 10(4):e0122246. PubMed ID: 25849568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoughtful Prescribing and Deprescribing.
    Pravodelov V
    Med Clin North Am; 2020 Sep; 104(5):751-765. PubMed ID: 32773043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polypharmacy and deprescribing in cardiology].
    Bobbio M
    G Ital Cardiol (Rome); 2020 Oct; 21(10):801-806. PubMed ID: 32968317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.